Details for Patent: 10,736,965
Summary for Patent: 10,736,965
| Title: | Risperidone biodegradable implant |
| Abstract: | The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention. |
| Inventor(s): | Steven Siegel, Karen Winey |
| Assignee: | University of Pennsylvania Penn |
| Application Number: | US16/174,083 |
|
Patent Claim Types: see list of patent claims | Composition; Device; |
Drugs Protected by US Patent 10,736,965
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,736,965
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005206143 | ⤷ Start Trial | |||
| Australia | 2006269927 | ⤷ Start Trial | |||
| Canada | 2553254 | ⤷ Start Trial | |||
| Canada | 2614601 | ⤷ Start Trial | |||
| China | 101287423 | ⤷ Start Trial | |||
| China | 103637977 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
